PharmaShots Weekly Snapshots (July 08 – July 12, 2024)
This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:
BioCity Biopharma Reports the P-II (2-SUCCEED) Study Data of SC0062 to Treat IgA Nephropathy
Read More: BioCity Biopharma
HilleVax Provides Update on P-IIb (NEST-IN1) Trial of HIL-214 to Prevent Acute Gastroenteritis (AGE) in Infants
Read More: HilleVax
Antidote Technologies and SEQSTER Join Forces to Improve Patient Identification & Enrollment for Clinical Trials
Read More: Antidote Technologies & SEQSTER
uniQure Reports Data from Two P-I/II Studies of AMT-130 for Treating Huntington’s Disease
Read More: uniQure
Pfizer Reports the Advancement of Danuglipron Development
Read More: Pfizer
Immutep Provides Data from the P-IIb (TACTI-003) Study of Eftilagimod Alfa to Treat Head and Neck Squamous Cell Carcinoma
Read More: Immutep
Hinova Pharmaceuticals’ HP518 Gains the US FDA’s Fast Track Designation to Treat Triple-Negative Breast Cancer (TNBC)
Read More: Hinova Pharmaceutical
Immorna Biotherapeutics Reports the US FDA’s IND Clearance to Commence P-I/II Trial of JCXH-211 IV for Solid Tumors
Read More: Immorna Biotherapeutics
Mirum Pharmaceuticals’ Livmarli Receives the EC’s Approval to Treat Progressive Familial Intrahepatic Cholestasis (PFIC)
Read More: Mirum Pharmaceuticals
Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis
Read More: Abata Therapeutics
Obsidian Therapeutics’ OBX-115 Receives the US FDA’s Fast Track Designation to Treat Advanced Melanoma
Read More: Obsidian Therapeutics
The NMPA Grants Breakthrough Therapy Designation to AusperBio’s AHB-137 for Treating Chronic Hepatitis B
Read More: AusperBio
Biophytis Reports the US FDA’s IND Clearance to Initiate the P-II Trial of BIO101 for Treating Obesity
Read More: Biophytis
AskBio’s (Bayer's Subsidiary) AB-1005 Gains the US FDA’s Fast Track and MHRA’s Innovation Passport Designations for Parkinson’s Disease
Read More: Bayer
AstraZeneca’s Tagrisso Plus Chemotherapy Receives Health Canada’s Approval to Treat Advanced Lung Cancer
Read More: AstraZeneca
Roche’s Accu-Chek SmartGuide CGM System Gains CE Mark for Diabetic Patients
Read More: Roche
Orthofix Medical Reports the US FDA’s Clearance of Fitbone Transport and Lengthening System
Read More: Orthofix Medical
Eli Lilly to Acquire Morphic Holdings for an Aggregate of ~$3.2B
Read More: Eli Lilly & Morphic Holdings
TuHURA Biosciences to Acquire Kineta’s KVA12123 for Treating Solid Tumors
Read More: TuHURA & Kineta
Ligand Pharmaceuticals Reports the Acquisition of APEIRON Biologics for $100M
Read More: Ligand Pharmaceuticals & APEIRON Biologics
Illumina Reports the Acquisition of Fluent BioSciences to Expand its Multiomics Portfolio
Read More: Illumina
Certara to Expand its Drug Discovery Software Capabilities Through the Acquisition of Chemaxon
Read More: Certara & Chemaxon
Evotec Partners with Pfizer for Drug Discovery Advancement Across France
Read More: Evotech & Pfizer
XyloCor Therapeutics Partners with SmartCella for its Technology to Deliver XC001 as a Treatment of Refractory Angina
Read More: XyloCor Therapeutics & SmartCella
Ipsen Teams Up with Foreseen Biotechnology to Develop FS001 for Solid Tumors
Read More: Ipsen & Biotechnology
Abeona Therapeutics Collaborates with Beacon Therapeutics to Develop AAV204 Capsid for Certain Ophthalmology Indications
Read More: Abeona Therapeutics & Beacon Therapeutics
AB Science Provides Update on P-II Trial Design of Masitinib for COVID-19
Read More: AB Science
The US FDA Grants Clearance to ImmersiveTouch’s Augmented Reality Surgical System
Read More: ImmersiveTouch
MEKanistic Therapeutics Reports Preclinical Results of MTX-531 for Cancer Treatment
Read More: MEKanistic Therapeutics
Sirnaomics Completes the Preclinical Study of STP125G for Treating Cardiovascular Diseases
Read More: Sirnaomics
Related Post: PharmaShots Weekly Snapshots (July 01 – July 05, 2024)
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.